×
Entertainment News
Technology News

ads

BioRestorative Therapies Sharply Higher After Inking Deal to Jointly Study Brown Adipose Tissue

BioRestorative Therapies Sharply Higher After Inking Deal to Jointly Study Brown Adipose Tissue

BioRestorative Therapies Inc. (BRTX) shares were up more than 17% in early-afternoon trade, just off its high for the day, after the development-stage biotech inked a two-year research agreement with Pfizer (PFE) to jointly study so-called brown fat and its potential therapeutic uses. BRTX shares were ahead 17.2% at 58 cents apiece, a penny under their session high. The stock has a 52-week range of 28 cents to $1.19 a share, declining 42% in value over the past year. Under the terms of the agreement, the companies plan work on a study measuring the metabolic function of brown adipose tissue, also further characterizing the identity of the human cell lines containing large numbers of iron-containing mitochondria, giving them their brown color compared to white fat cells. Both firms will be able to use the resulting research to develop new obesity-related therapies for Type 2 diabetes, hypertension and other diseases. PFE was 0.7% higher in recent trade at $29.78 a share, climbing as high as $29.87 apiece during the session.

BioRestorative Therapies Sharply Higher After Inking Deal to Jointly Study Brown Adipose Tissue

ads